Cervical Squamous Intraepithelial Neoplasia 3

Cervical Squamous Intraepithelial Neoplasia 3 — Trials · CancerIndex

Clinical trials

Registered studies

8 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

clinicaltrialsPublishedShowing 1–8 of 8 studies · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT04712851	Pembrolizumab for the Treatment of Cervical Intraepithelial Neoplasia	recruiting	Phase 2	25	Jonsson Comprehensive Cancer CenterOTHER	1	Mar 10, 2026	clinicaltrials
NCT07211204	Comparison Of Cytology And Molecular Screening For Detecting Cervical Reactive Cellular Changes In General Population	withdrawn	N/A	0	Timser SAPI de CVINDUSTRY	1	Mar 3, 2026	clinicaltrials
NCT03267680	IRX-2 Regimen in Treating Women With Cervical Squamous Intraepithelial Neoplasia 3 or Squamous Vulvar Intraepithelial Neoplasia 3	terminated	Phase 2	10	University of Southern CaliforniaOTHER	1	Apr 13, 2025	clinicaltrials
NCT03196180	Topical Fluorouracil and Imiquimod in Treating Patients With High-Grade Cervical Intraepithelial Neoplasia

Data updated 22 days agoSource updated Mar 10, 2026source: clinicaltrials